Efficacy of sorafenib, molecular targeting drug, for advanced hepatocellular carcinoma.

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 37, Issue 10, 2010, Pages 1883-1886

  Kuzuya, Teiji ^a   Tsuchiya, Kaoru ^b   Izumi, Namiki ^b  

^a MUSASHINO RED CROSS HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZENESULFONIC ACID DERIVATIVE; PYRIDINE DERIVATIVE; SORAFENIB; VASCULOTROPIN RECEPTOR;

ARTICLE; DRUG ANTAGONISM; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PHASE 3 CLINICAL TRIAL;

ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; LIVER NEOPLASMS; PYRIDINES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;

EID: 78149488825     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)